Street Cred Ep 9 | Ad Com for COVID-19: Vaccines Likely to Underwhelm

Rick Weissenstein, health care policy analyst at Cowen Washington Research Group looks at the latest in health care policy on Capitol Hill and the administration this month. In this episode, he speaks with Mike McCaughan, Founding Partner of Prevision Policy about what to expect from the FDA advisory committee meeting to discuss the COVID-19 vaccines on October 22nd, how the upcoming election could affect the FDA and the impact of executive orders on drug pricing.

Press play below to listen to their conversation.

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.

More Like This

Video
Ahead of the Curve®

How Election 2020 Will Impact Transportation

Read More
Ahead of the Curve®

Updated Survey: Impact of COVID-19 on Medical Technology Spending

Read More
Video
Ahead of the Curve®

2020 Election Deep Dive

Read More